All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

USPTO Proposes Rules That Would Limit Public Challenges to Patents

The U.S. Patent and Trademark Office (USPTO) has proposed new rules that would effectively end the public’s ability to challenge improperly granted patents at the Patent Office itself. We need EFF…

Read the full article
iamnothere7mo ago7 min readenOpinion

You might also wanna read

Small Inventors Struggle to Navigate Complex US Patent System

Independent inventors and small innovators in the United States are facing significant challenges due to the increasingly complicated patent

ShortSingh·5d ago

Defend Public Health Urges Congress to Block OMB Rules on Federal Research Grants

New regulations issued last week by the Office of Management and Budget regarding federal research grants amount to a declaration of war on

defendpublichealth.org·1mo ago

OMB Proposal to Rewrite Federal Grant Rules Threatens US Scientific Research Enterprise

Open-closed model gap, evals in the biorisk hierarchy, DARPA AI Forge, refusal benchmarks, OpenAI’s Rosalind Biodefense

blog.stephenturner.us·1mo ago

To Address “Changed Circumstances” After Institution, USPTO Director Extends Deadline for Seeking Director Review of Institution Decisions

In a precedential and sua sponte Director Review decision, USPTO Director Squires recently vacated three related institution decisions nearl

akingump.com·4d ago

U.S. restrictions on Chinese biotechnology could harm patients, argues editorial

Patients benefit from faster, cheaper treatments, wherever they are invented

econ.st·27d ago

U.S. restrictions on Chinese biotech could harm patients, argues editorial

Patients benefit from faster, cheaper treatments, wherever they are invented

economist.com·26d ago

U.S. restrictions on Chinese biotech could harm patients, argues editorial

Patients benefit from faster, cheaper treatments, wherever they are invented

The Economist·26d ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.